Cladribine Market Overview Analysis, Trends, Share, Size, Type & Future Forecast to 2034
The Cladribine market is gaining traction globally, driven by its increasing use in treating multiple sclerosis (MS) and certain cancers such as hairy cell leukemia. Cladribine, a synthetic purine nucleoside analogue, disrupts DNA synthesis in rapidly dividing cells, making it an effective treatment for these proliferative conditions. Originally approved for hematologic cancers, Cladribine has...
0 Comments 0 Shares 441 Views 0 Reviews